DK0966975T3 - Brug af 13C- eller 14C-mærkede aminosyrer eller peptider som midler til diagnosticering af pancreatisk eksokrin funktion - Google Patents

Brug af 13C- eller 14C-mærkede aminosyrer eller peptider som midler til diagnosticering af pancreatisk eksokrin funktion

Info

Publication number
DK0966975T3
DK0966975T3 DK99304388T DK99304388T DK0966975T3 DK 0966975 T3 DK0966975 T3 DK 0966975T3 DK 99304388 T DK99304388 T DK 99304388T DK 99304388 T DK99304388 T DK 99304388T DK 0966975 T3 DK0966975 T3 DK 0966975T3
Authority
DK
Denmark
Prior art keywords
peptides
diagnosis
agents
amino acids
labeled amino
Prior art date
Application number
DK99304388T
Other languages
Danish (da)
English (en)
Inventor
Tadashi Kohno
Isaburo Hosoi
Junko Ohshima
Kunihiko Shibata
Asuka Ito
Original Assignee
Tokyo Gas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Gas Co Ltd filed Critical Tokyo Gas Co Ltd
Application granted granted Critical
Publication of DK0966975T3 publication Critical patent/DK0966975T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Atmospheric Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99304388T 1998-06-05 1999-06-04 Brug af 13C- eller 14C-mærkede aminosyrer eller peptider som midler til diagnosticering af pancreatisk eksokrin funktion DK0966975T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15785598 1998-06-05
JP14949699A JP3340699B2 (ja) 1998-06-05 1999-05-28 膵外分泌機能診断剤
EP99304388A EP0966975B1 (fr) 1998-06-05 1999-06-04 Utilisation d' acides aminés ou de peptides marqués au 13C ou au 14C comme agents de diagnostique de la fonction exocrine pancréatique

Publications (1)

Publication Number Publication Date
DK0966975T3 true DK0966975T3 (da) 2005-10-03

Family

ID=26479372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99304388T DK0966975T3 (da) 1998-06-05 1999-06-04 Brug af 13C- eller 14C-mærkede aminosyrer eller peptider som midler til diagnosticering af pancreatisk eksokrin funktion

Country Status (10)

Country Link
EP (1) EP0966975B1 (fr)
JP (1) JP3340699B2 (fr)
AU (1) AU729896B2 (fr)
CA (1) CA2273549C (fr)
DE (1) DE69927089T2 (fr)
DK (1) DK0966975T3 (fr)
ES (1) ES2249873T3 (fr)
NO (1) NO323757B1 (fr)
NZ (1) NZ336116A (fr)
PT (1) PT966975E (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284219B1 (en) 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
JP2001139498A (ja) * 1999-11-15 2001-05-22 Tokyo Gas Co Ltd 膵外分泌機能診断剤
US7232559B1 (en) * 1999-06-04 2007-06-19 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
US7125683B2 (en) * 2000-09-07 2006-10-24 Tokyo Gas Company Limited Preparations for diagnosis extrapancreatic secretory function
DE60216293T2 (de) * 2001-08-10 2007-06-21 Tokyo Gas Co. Ltd. Diagnostisches mittel für die exokrine pankreasfunktion
US7781396B2 (en) 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
NZ534462A (en) * 2002-02-21 2007-06-29 Tokyo Gas Co Ltd Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or prodrugs thereof
MXPA04008371A (es) * 2002-02-27 2005-05-17 Cambridge Isotope Lab Inc Uso de sustancia marcada con carbono 13 para medir la funcion pulmonar.
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
WO2004060791A1 (fr) 2003-01-07 2004-07-22 Ramot At Tel Aviv University Ltd. Nanostructures de peptides encapsulant une matiere etrangere ainsi que procede de fabrication correspondant
CN101415724B (zh) 2003-06-30 2015-12-02 特拉维夫大学未来科技开发有限公司 肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法
EP1663199B1 (fr) 2003-09-25 2013-04-03 Tel Aviv University Future Technology Development L.P. Compositions et methodes d'utilisation de ces compositions pour le traitement des maladies associees a la substance amyloide
WO2005031362A2 (fr) 2003-10-02 2005-04-07 Ramot At Tel Aviv University Ltd. Nouveaux agents antibacteriens et procedes permettant de les identifier et de les utiliser
WO2006013552A2 (fr) 2004-08-02 2006-02-09 Ramot At Tel Aviv University Ltd. Articles de nanostructures a base de peptides et leur procede de formation
EP1793816B1 (fr) 2004-08-19 2012-01-04 Tel Aviv University Future Technology Development L.P. Compositions pour le traitement de maladies associées à l'amyloide
US7786086B2 (en) 2004-09-08 2010-08-31 Ramot At Tel-Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
CN101291683B (zh) 2004-11-24 2011-08-17 纽普罗研究有限公司 治疗疾病的方法和组合物
US10004828B2 (en) 2005-10-11 2018-06-26 Romat at Tel-Aviv University Ltd. Self-assembled Fmoc-ff hydrogels
US7879212B2 (en) 2005-11-03 2011-02-01 Ramot At Tel-Aviv University Ltd. Peptide nanostructure-coated electrodes
CA2647835A1 (fr) 2006-03-28 2007-10-04 Neopro Labs, Llc Methodes et compositions pour traiter des conditions
EP2152725A1 (fr) 2007-05-17 2010-02-17 Neopro Labs, LLC Formes cristallines et amorphes d'un peptide
TR2021004329A2 (tr) * 2021-03-05 2022-09-21 Argeron Medikal Arastirma Sanayi Ve Ticaret Anonim Sirketi Bi̇yoki̇myasal tibbi̇ tani ki̇ti̇
JP2024510435A (ja) 2021-03-18 2024-03-07 シージェン インコーポレイテッド 生体活性化合物の内部移行複合体からの選択的薬物放出

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279886A (en) * 1979-01-02 1981-07-21 University Patents, Inc. Test for pancreatic exocrine function
US4676974A (en) * 1984-05-17 1987-06-30 The Regents Of The University Of California Breath test for pancreatic exocrine function
US5506147A (en) 1993-04-15 1996-04-09 Kolhouse; J. Fred Non-invasive evaluation of maldigestion and malaborption
ATE253381T1 (de) * 1997-02-03 2003-11-15 Mallinckrodt Inc Verfahren zur detektion und lokalisation maligner meschlicher tumore des pankreas
US6284219B1 (en) * 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
NZ337946A (en) * 1998-09-25 2001-11-30 Tokyo Gas Co Ltd C-13 labelled oligosaccharides and polysaccharides useful as diagnostic agents for pancreatic exocrine function
JP2001139498A (ja) * 1999-11-15 2001-05-22 Tokyo Gas Co Ltd 膵外分泌機能診断剤

Also Published As

Publication number Publication date
NO992727L (no) 1999-12-06
CA2273549C (fr) 2006-10-24
NZ336116A (en) 2000-10-27
JP2000053697A (ja) 2000-02-22
AU729896B2 (en) 2001-02-15
NO992727D0 (no) 1999-06-04
JP3340699B2 (ja) 2002-11-05
DE69927089D1 (de) 2005-10-13
CA2273549A1 (fr) 1999-12-05
EP0966975A3 (fr) 2002-04-17
EP0966975B1 (fr) 2005-09-07
PT966975E (pt) 2005-11-30
ES2249873T3 (es) 2006-04-01
EP0966975A2 (fr) 1999-12-29
AU3316899A (en) 1999-12-16
NO323757B1 (no) 2007-07-02
DE69927089T2 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
NO992727L (no) Diagnostiske midler for eksokrin funksjon til bukspyttkjertelen
DE69816350D1 (de) Technik zur Erkennung von Bildstellungsfehlern
NO995690D0 (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
DK1036179T3 (da) Fremgangsmåde til fremstilling af polypeptider med egnet glucosilering
DE122008000021I2 (de) Sulfonamidderivate als Wirkstoff-Vorläufer vom Inhibitoren der Aspartyl-Protease
EP1124598A4 (fr) Systeme de diagnostic de l'incontinence urinaire
EE04156B1 (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
DK0970175T3 (da) Konditioneringsopløsninger til pleje af hårde kontaktlinser
MA26842A1 (fr) Amino-acides bicycliques servant d'agents pharmaceutiques
ATE240107T1 (de) Neue verbesserte formulierung zur behandlung der osteoporose
DE60024349D1 (de) Kreuzgelenk
CU23047A3 (es) Derivados de aminoacidos halogenados utiles como inhibidores de la oxido nitrico-sintasa.
FR2812916B1 (fr) Joint universel homocinetique de type tripode
FI974099A0 (fi) Dricksburkslock som kan oeppnas med en hand
ID23371A (id) Pemulihan heksametilenediamina dari campuran-campuran yang sama
DE69837588D1 (de) C4 zyklus des pck types
NO983754D0 (no) Tettemetoder for hjelpebr°nnb¾ringer
DE69820942D1 (de) Verfahren zum Steuern der Tonerkonzentration
DE59813079D1 (de) Fräszahn zur Erdbearbeitung
NO20012232D0 (no) Enzymatisk amidering av peptider
NO20004167L (no) Kaspase-8 interagerende proteiner
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
DE69934233D1 (de) Aspergillus Fumigatus Peptidsequenzen zur Diagnose von Aspergillose
NO20012939D0 (no) Substituerte heterocykliske acyltripeptider for anvendelse som trombin-receptor-modulatorer
NO950971D0 (no) Ikke-cykliske chelatdannere på basis av aminodiakylfosforoksyder for fremstilling av technetium- eller rheniumkomplekser